Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
Commentary|Videos|August 18, 2025

The Reality of Operational Flexibility for Trial Sites

In this video interview, Caroline Potts, general manager of sites and patient services at Medical Research Network (MRN), discusses the challenges of achieving true operational flexibility in clinical trials—highlighting how SOPs, staffing, and budget constraints often limit site adaptability and contribute to staff burnout.

In a recent video interview Applied Clinical Trials, Caroline Potts, general manager of sites and patient services, Medical Research Network (MRN), discussed operational flexibility in clinical trials, emphasizing the need to avoid staff burnout due to inflexible SOPs and budget constraints. She highlighted strategies such as in-home visits and community outreach as essential for reducing recruitment delays and improving trial diversity. Potts also touched on budgetary issues as a major barrier to patient-centric models, with a call for better dialogue and innovative solutions. She stressed the importance of community engagement, temporary clinic sites, and collaborative efforts among key stakeholders to better serve diverse populations in clinical trials.

ACT: What does operational flexibility really look like for sites today? How can it be implemented without adding to staff burnout?

Potts: I think the key point there is the staff burnout. I think everyone likes to genuinely believe that operational flexibility exists, and I'm just not sure that that is the true lived experience of site staff. I think that everyone wants to do a good job, everyone wants to be able to offer solutions that perhaps are nonstandard, or seen as nonstandard, but SOPs, budgetary constraints, time constraints, availability of staff, availability of patients, all of those things can—more often than not—count against this idea of having the flexibility. I think that it does run the risk of leading to staff burnout as a result of that, unfortunately. It's a great concept, and I think everyone should still continue to try to strive for it, but I think the reality is a little bit different to that.


Related to this article

What Needs to Happen Beyond the Clinical Trial Modernization Act
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.